Home Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech
 

Keywords :   


Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

2014-12-01 14:52:54| Biotech - Topix.net

The CEO who sold Idenix Pharmaceuticals to Merck & Co. in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.

Tags: sale head ceo cambridge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Kim Madigan to chair 2025 FTA Fall Technical Conference
05.11PM responds to Sir Alan Bates after repeated requests
More »